Physician profile
Jerry Drucker
NPI 1770581159
$2,259.09
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,790 · 2020: $216 · 2021: $253.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $975.00 | 2019 | |
| Sanofi-Aventis U.S. LLC | $248.33 | 2019-2020 | |
| Novo Nordisk INC | $231.89 | 2019-2020 | |
| Dexcom, INC. | $199.36 | 2019-2021 | |
| Amgen INC. | $142.40 | 2019-2021 | |
| Shire North American Group INC | $70.88 | 2019 | |
| Recordati_rare_diseases_inc. | $59.89 | 2021 | |
| Tandem Diabetes Care, INC. | $43.84 | 2019-2021 | |
| Ibsa Pharma INC. | $35.01 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $31.42 | 2019-2021 | |
| Becton, Dickinson and Company | $31.23 | 2019 | |
| Merck Sharp & Dohme LLC | $24.78 | 2019-2021 | |
| Abbott Laboratories | $24.55 | 2019-2020 | |
| Radius Health, INC. | $24.34 | 2019 | |
| Horizon Therapeutics Plc | $20.89 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lifescan, INC. | $20.65 | 2021 | |
| Mannkind Corporation | $18.23 | 2019 | |
| Medtronic Minimed, INC. | $15.52 | 2019 | |
| Insulet Corporation | $15.35 | 2019 | |
| Pfizer INC. | $12.87 | 2019 | |
| Lilly USA, LLC | $12.66 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Drucker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.